Mackay Shields’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
Mackay Shields's ANIP Position: Q2 2021 in Review
Mackay Shields sold out of ANI Pharmaceuticals (ANIP) in Q2 2021, closing a stake of 8,200 shares — an estimated $297K sold.
Mackay Shields first reported a position in ANIP in Q1 2018 and held it in 11 quarters. The position peaked at $3.97M in Q2 2019. 116 funds tracked by Wall St. Rank hold ANIP as of Q2 2021.
- Mackay Shields reported no remaining ANI Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
- Mackay Shields sold 8,200 ANI Pharmaceuticals shares in Q2 2021, an estimated $297K.
- Mackay Shields first reported a position in ANI Pharmaceuticals in Q1 2018 and held it in 11 quarters.
- Mackay Shields's ANI Pharmaceuticals position peaked at $3.97M in Q2 2019.
- 116 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2021.
Based on Mackay Shields's 13F filing for Q2 2021, filed 13 Aug 2021.